Delivery Order SPE2DB22D1106-SPE2DB25FFJA4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,839.49 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials with diluents, with a firm fixed price and an ultimate completion date of June 3, 2025. This non-set-aside competitive award was placed with AmerisourceBergen's Corporate Office located in Conshohocken, Pennsylvania, the company's headquarters. The delivery order represents a child contract under a larger vehicle supporting federal pharmaceutical procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $14,758.51 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price delivery order was issued with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $22,966.57 delivery order for Vivitrol 380 mg vial-diluents, with a completion date of August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is classified as a child contract under AmerisourceBergen's larger pharmaceutical supply agreements with DLA. The pharmaceutical products will be delivered to AmerisourceBergen's location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a $8,149.00 delivery order to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents. The contract, issued September 8, 2025, with a completion date of September 9, 2025, represents a firm fixed-price award with no set-aside designation. The work will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $2,002.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vials with diluents, with an ultimate completion date of June 30, 2025. This non-set-aside award was issued on June 27, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The place of performance is...
- The Defense Logistics Agency awarded a $1,001.17 firm fixed price delivery order to AmerisourceBergen Drug Corp for VIVITROL 380 MG vial-diluents, with an ultimate completion date of September 5, 2025. This non-set-aside contract was competitively awarded and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The award demonstrates continued federal reliance on AmerisourceBergen as a critical pharmaceutical distributor for military...
- The Defense Logistics Agency awarded a delivery order valued at $4,004.68 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vials with diluents. This firm fixed price delivery order, issued on August 20, 2025, represents a pediatric or adult pharmaceutical supply requirement with an ultimate completion date of August 21, 2025. The contract was awarded on a competitive basis without set-aside designation, with performance to be fulfilled at AmerisourceBergen's facility in...
- The Defense Logistics Agency awarded a delivery order valued at $11,558.70 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of September 17, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which carries a $999,999,999.00 ceiling value and extends through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents with a ceiling value of $1,179.61 under a firm fixed price contract. This competitive award, issued on September 8, 2025, with an ultimate completion date of September 9, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at the contractor's headquarters location in...
- The Defense Logistics Agency awarded a delivery order valued at $4,357.27 to AmerisourceBergen Drug Corp for the supply of Vivitrol 380 mg vial-diluents, with an ultimate completion date of September 17, 2025. This is a firm fixed price contract with no set-aside designation, reflecting competitive procurement practices. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is executed under...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFJA4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,005.85 to AmerisourceBergen Drug Corp for Vivitrol 380 mg vial-diluents, with an ultimate completion date of September 12, 2025. This non-set-aside contract employs firm fixed price terms and represents a pediatric delivery order under AmerisourceBergen's existing Indefinite Delivery Contract vehicle. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's broader $999,999,999 Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen is positioned as a critical vendor for federal medical procurement, supplying an extensive portfolio of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract awards with DLA demonstrate consistent competitively awarded success across diverse therapeutic domains and order values, from sub-$100 transactions to substantial orders exceeding $45,000.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.0k | 9/11/25 |